The proposal to hold the state’s medical market to the same safety standards as its recreational counterpart reflects a reckoning for the industry, and the bill still faces significant opposition from the industry.
cannabis
Livermore Falls board gets public input before vote on retail cannabis moratorium
Select Board members reviewed the updated proposal, saying existing businesses will not be affected by a moratorium.
Farmington to look further into proposal to lower cannabis license fees
Farmington officials said they will review more details of a proposed warrant article before deciding whether to put it before voters.
Medical cannabis products pulled from Maine shelves after pesticides detected
Regulators issued a patient advisory after testing found unsafe pesticide levels in several cannabis concentrates sold at MarijuanaVille locations statewide.
Livermore Falls lawyer to review cannabis moratorium with ‘fine-tooth comb’
The Select Board voted Jan. 20 to have language in the proposed 180-day moratorium on new retail medical marijuana businesses reviewed.
Cannabis opponents accused of misrepresenting Maine referendum
‘You have a right to lie under the First Amendment,’ Maine Secretary of State Shenna Bellows said, noting there’s little she can do about the alleged trickery.
Livermore Falls weighs possible moratorium on cannabis businesses
At its Jan. 6 meeting, the Select Board said current fees will stay the same while it reviews the cannabis ordinance.
Maine’s cannabis industry has mixed feelings over federal drug reclassification
Industry members are cautiously optimistic that rescheduling marijuana to a lower tier is one step closer to full legalization, but the fear of a ‘Big Pharma’ or federal takeover looms large.
Livermore Falls weighs cannabis license fees amid high dispensary density
Livermore Falls Select Board members tabled action on proposed increases to cannabis licensing fees after considering costs and the density of cannabis businesses.
Cannabis recalls spark questions about chemical testing in Maine
Three recalls tied to the same cannabis producer are raising questions about transparency and regulatory follow-through.